TuisLSTA • NASDAQ
add
Lisata Therapeutics Inc
Vorige sluiting
$2,47
Dagwisseling
$2,31 - $2,53
Jaarwisseling
$1,87 - $4,20
Markkapitalisasie
21,81 m USD
Gemiddelde volume
11,54 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Yahoo Finance
22 uur gelede
These Growth Stocks Are Crushing the S&P 500 in 2025. Should You Buy Them?
0,74%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,00 m | — |
Bedryfskoste | 5,95 m | -1,26% |
Netto inkomste | -4,61 m | 14,07% |
Netto winsgrens | -461,00 | — |
Wins per aandeel | -0,55 | 16,67% |
EBITDA | -4,91 m | 17,90% |
Effektiewe belastingkoers | 0,00% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 31,24 m | -38,17% |
Totale bates | 35,00 m | -36,00% |
Totale aanspreeklikheid | 5,68 m | -16,40% |
Totale ekwiteit | 29,32 m | — |
Uitstaande aandele | 27,70 m | — |
Prys om te bespreek | 0,70 | — |
Opbrengs op bates | -33,80% | — |
Opbrengs op kapitaal | -39,23% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -4,61 m | 14,07% |
Kontant van bedrywe | -4,53 m | -11,28% |
Kontant van beleggings | 1,39 m | 124,31% |
Kontant van finansiering | -96,00 k | -500,00% |
Netto kontantverandering | -3,30 m | 66,45% |
Beskikbare kontantvloei | -2,95 m | -25,90% |
Meer oor
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Gestig
1980
Webwerf
Werknemers
26
